Jazz Pharmaceuticals plc Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale
Jazz Pharmaceuticals plc (JAZZ) reported Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale of $0 for the 12-month period ending 2014-12-31, per its 10-K filed 2015-02-24.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities · last filed 2015-02-24
- Jazz Pharmaceuticals plc proceeds from maturities, prepayments and calls of debt securities, available-for-sale for the quarter ending 2013-12-31 was $0.00.
- Jazz Pharmaceuticals plc proceeds from maturities, prepayments and calls of debt securities, available-for-sale for the quarter ending 2013-09-30 was $0.00.
- Jazz Pharmaceuticals plc proceeds from maturities, prepayments and calls of debt securities, available-for-sale for the quarter ending 2013-06-30 was $0.00, a 100.00% decline year-over-year.
- Jazz Pharmaceuticals plc proceeds from maturities, prepayments and calls of debt securities, available-for-sale for the quarter ending 2013-03-31 was $0.00, a 100.00% decline year-over-year.
- Jazz Pharmaceuticals plc proceeds from maturities, prepayments and calls of debt securities, available-for-sale for fiscal 2014 was $0.00.
- Jazz Pharmaceuticals plc proceeds from maturities, prepayments and calls of debt securities, available-for-sale for fiscal 2013 was $0.00, a 100.00% decline from fiscal 2012.
- Jazz Pharmaceuticals plc proceeds from maturities, prepayments and calls of debt securities, available-for-sale for fiscal 2012 was $31.99M, a 693.16% increase from fiscal 2011.
- Jazz Pharmaceuticals plc proceeds from maturities, prepayments and calls of debt securities, available-for-sale for fiscal 2011 was $4.03M.
| Period end | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 3 month | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 6 month | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 9 month | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 12 month |
|---|---|---|---|---|
| 2014-12-31 | $0.00 10-K · filed 2015-02-24 | |||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $0.00 derived: sum of 2 quarters · filed 2015-02-24 | $0.00 derived: sum of 3 quarters · filed 2015-02-24 | $0.00 10-K · filed 2015-02-24 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | $0.00 derived: sum of 2 quarters · filed 2013-11-05 | $0.00 10-Q · filed 2013-11-05 | $0.00 derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $0.00 10-Q · filed 2013-08-06 | $0.00 derived: sum of 3 quarters · filed 2015-02-24 | $0.00 derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-03-31 | $0.00 10-Q · filed 2013-05-07 | $0.00 derived: sum of 2 quarters · filed 2015-02-24 | $0.00 derived: sum of 3 quarters · filed 2015-02-24 | $14.15M derived: sum of 4 quarters · filed 2015-02-24 |
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $0.00 derived: sum of 2 quarters · filed 2015-02-24 | $14.15M derived: sum of 3 quarters · filed 2015-02-24 | $31.99M 10-K · filed 2015-02-24 |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | $14.15M derived: sum of 2 quarters · filed 2013-11-05 | $31.99M 10-Q · filed 2013-11-05 | $36.02M derived: sum of 4 quarters · filed 2014-02-25 |
| 2012-06-30 | $14.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $31.99M 10-Q · filed 2013-08-06 | $36.02M derived: sum of 3 quarters · filed 2014-02-25 | |
| 2012-03-31 | $17.84M 10-Q · filed 2013-05-07 | $21.87M derived: sum of 2 quarters · filed 2014-02-25 | ||
| 2011-12-31 | $4.03M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $4.03M 10-K · filed 2014-02-25 | ||
| 2011-09-30 | $0.00 10-Q · filed 2012-11-09 | |||
| 2010-12-31 | $0.00 10-K · filed 2013-02-26 | |||
| 2009-12-31 | $1.00M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |